Actively Recruiting
Segmentectomy for Solid-dominant Lung Cancer
Led by Fudan University · Updated on 2024-10-10
277
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a clinical trial from Eastern Cooperative Thoracic Oncology Project (ECTOP), numbered as ECTOP-1025. The goal of this clinical trial is to confirm the theraputic effect of segmentectomy for solid-dominant invasive lung cancer with size of 2-3cm. The main questions it aims to answer are: * The 5-year disease-free survival of patients having solid-dominant invasive lung cancer with size of 2-3cm; * The post-operative lung function tests after receiving segmentectomy. Participants will receive segmentectomy as the surgical procedure.
CONDITIONS
Official Title
Segmentectomy for Solid-dominant Lung Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients who sign the informed consent form and are willing to complete the study according to the plan
- Aged from 18 to 80 years old
- ECOG performance status of 0 or 1
- No previous lung cancer surgery
- Confirmed invasive lung adenocarcinoma intraoperatively or postoperatively
- Presence of ground glass-dominant lung nodules
- Consolidation-to-tumor ratio (CTR) between 0.5 and 1, tumor size between 2 and 3 cm
- No lymph node involvement (cN0) and no distant metastasis
- Tumors assessed as completely resectable by surgeons
- No prior chemotherapy or radiotherapy for lung cancer
You will not qualify if you...
- Consolidation-to-tumor ratio (CTR) not between 0.5 and 1 or tumor size not between 2 and 3 cm
- Tumors assessed as not completely resectable by surgeons
- No pathological or cytological diagnosis of lung adenocarcinoma
- Previous lung cancer surgery
- Previous radiotherapy or chemotherapy for lung cancer
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China
Actively Recruiting
Research Team
F
Fangqiu Fu, M.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here